Best Pharmaceutical Stocks To Buy In 2023
vaccinesExplore Stocklytics' meticulously researched selection of the Best Pharmaceutical Stocks to Buy in 2023, focusing on companies within the pharmaceutical sector. These picks highlight pharmaceutical stocks involved in drug development, research, and healthcare innovations. Stocklytics identifies pharmaceutical stocks poised for growth, considering factors like drug pipelines, regulatory approvals, and market demand. Whether you're interested in therapeutic breakthroughs, medical research, or healthcare advancements, Stocklytics' selections offer opportunities to invest in companies driving innovation and potential breakthroughs in the pharmaceutical industry in the coming year.
| name | Price | $ Change | % Change | Market Cap | Score language | Tags | Volume | Avg. Volume | Technicals | Dividend Y | ROI 1Y | Last 7 Days | |||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
 LLYEli Lilly & Co | $767.76 | $10.41 | arrow_drop_up1.37% | $690.45B | High Quality | 9.94M | 787.15 | Neutralremove | 0.78% | 34.64% | |||||
 AMGNAmgen | $263.38 | $2.23 | arrow_drop_up0.85% | $141.57B | S&P500 | 13.68M | 264.70 | Neutralremove | 3.64% | -4.28% | |||||
 GILDGilead Sciences | $92.57 | $1.48 | arrow_drop_up1.62% | $115.36B | S&P500 | 22.53M | 92.43 | Neutralremove | 3.38% | 17.78% | |||||
CAHCardinal Health | $118.28 | $1.31 | arrow_drop_up1.11% | $28.62B | S&P500 | 9.31M | 118.18 | Neutralremove | 1.74% | 19.33% | |||||
 CVSCVS Health | $44.36 | $0.57 | arrow_drop_up1.30% | $55.82B | S&P500 | 21.44M | 44.30 | Buykeyboard_arrow_up | 6.08% | -42.56% | |||||
 MCKMcKesson | $579.74 | -$0.23 | arrow_drop_down0.03% | $73.59B | S&P500 | 2.05M | 579.41 | Neutralremove | 0.49% | 29.99% | |||||
 BMYBristol-Myers Squibb Co | $57.33 | $0.97 | arrow_drop_up1.72% | $116.27B | S&P500 | 48.21M | 57.04 | Neutralremove | 4.36% | 12.50% | |||||
 JNJJohnson & Johnson | $144.47 | $0.83 | arrow_drop_up0.57% | $347.82B | S&P500 | 17.70M | 144.40 | Neutralremove | 3.43% | -5.74% | |||||
 PFEPfizer | $26.36 | $0.59 | arrow_drop_up2.28% | $149.38B | S&P500 | 116.33M | 26.30 | Neutralremove | 6.67% | -4.59% |
About Best Pharmaceutical Stocks To Buy In 2023
Explore Stocklytics' meticulously researched selection of the Best Pharmaceutical Stocks to Buy in 2023, focusing on companies within the pharmaceutical sector. These picks highlight pharmaceutical stocks involved in drug development, research, and healthcare innovations. Stocklytics identifies pharmaceutical stocks poised for growth, considering factors like drug pipelines, regulatory approvals, and market demand. Whether you're interested in therapeutic breakthroughs, medical research, or healthcare advancements, Stocklytics' selections offer opportunities to invest in companies driving innovation and potential breakthroughs in the pharmaceutical industry in the coming year.
Discover the Power of Stocklytics Tools
Our suite of tools empowers you to make informed decisions, seize opportunities, and stay ahead in the competitive trading world.
See Stocklytics Tools